Clinical Features, Neuropathology, and Surgical Outcome in Patients With Refractory Epilepsy and Brain Somatic Variants in the SLC35A2 Gene.
Barba, C; Blumcke, I; Winawer, MR; Hartlieb, T; Kang, HC; Grisotto, L; Chipaux, M; Bien, CG; Heřmanovská, B; Porter, BE; Lidov, HGW; Cetica, V; Woermann, FG; Lopez-Rivera, JA; Canoll, PD; Mader, I; DIncerti, L; Baldassari, S; Yang, E; Gaballa, A; Vogel, H; Straka, B; Macconi, L; Polster, T; Grant, GA; Krsková, L; Shin, HJ; Ko, A; Crino, PB; Krsek, P; Lee, JH; Lal, D; Baulac, S; Poduri, A; Guerrini, R;
Neurology. 2023; 100(5):e528-e542
Full papers/articles (Journal)

"Bridging the Gap" international ECLS training and simulation - evaluation of the 10th educational corner on EuroELSO congress 2022 in London, United Kingdom.
Cvetkovic, M; Antonini, MV; Rosenberg, A; Meadows, CI; Dąbrowski, M; Puslecki, M; Fawzy Hassan, I; Fowles, JA; OCallaghan, M; Stefaniak, S; Riera, J; Barrett, NA; Bělohlávek, J; Di Nardo, M; Hoskote, A; Swol, J;
Perfusion. 2023; 38(1_suppl):3-12
Full papers/articles (Journal)

Refractory out-of-hospital cardiac arrest and extracorporeal cardiopulmonary resuscitation: A meta-analysis of randomized trials.
Scquizzato, T; Bonaccorso, A; Swol, J; Gamberini, L; Scandroglio, AM; Landoni, G; Zangrillo, A;
Artif Organs. 2023; 47(5):806-816
Reviews

A case report: New-onset refractory status epilepticus in a patient with FASTKD2-related mitochondrial disease.
Astner-Rohracher, A; Mauritz, M; Leitinger, M; Rossini, F; Kalss, G; Neuray, C; Retter, E; Wortmann, SB; Achleitner, MT; Mayr, JA; Trinka, E;
Front Neurol. 2022; 13: 1063733
Case Reports

From Interferon to Checkpoint Inhibition Therapy-A Systematic Review of New Immune-Modulating Agents in Bacillus Calmette-Guérin (BCG) Refractory Non-Muscle-Invasive Bladder Cancer (NMIBC).
Deininger, S; Törzsök, P; Mitterberger, M; Pallauf, M; Oswald, D; Deininger, C; Lusuardi, L;
Cancers (Basel). 2022; 14(3):
Reviews

An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real-world practice setting: A report from the Fenfluramine European Early Access Program
Guerrini, R; Specchio, N; Aledo-Serrano, A; Pringsheim, M; Darra, F; Mayer, T; Gil-Nagel, A; Polster, T; Zuberi, SM; Lothe, A; Gammaitoni, A; Strzelczyk, A
EPILEPSIA OPEN. 2022;
Full papers/articles (Journal)

Unraveling the enigma of new-onset refractory status epilepticus: a systematic review of aetiologies.
Lattanzi, S; Leitinger, M; Rocchi, C; Salvemini, S; Matricardi, S; Brigo, F; Meletti, S; Trinka, E
Eur J Neurol. 2022; 29(2):626-647
Reviews

New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES) of unknown aetiology: A comparison of the incomparable?
Nausch, E; Schaffeldt, L; Tautorat, I; Margraf, NG; Häusler, M; Kluger, G; Kellinghaus, C; Borzikowsky, C; Laufs, H; van Baalen, A;
Seizure. 2022; 96:18-21
Full papers/articles (Journal)

Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort Study.
Nowakowski, GS; Yoon, DH; Peters, A; Mondello, P; Joffe, E; Fleury, I; Greil, R; Ku, M; Marks, R; Kim, K; Zinzani, PL; Trotman, J; Huang, D; Waltl, EE; Winderlich, M; Kurukulasuriya, NC; Ambarkhane, S; Hess, G; Salles, G
CLIN CANCER RES. 2022; 28(18): 4003-4017.
Full papers/articles (Journal)

Accidental Hypothermia: 2021 Update.
Paal, P; Pasquier, M; Darocha, T; Lechner, R; Kosinski, S; Wallner, B; Zafren, K; Brugger, H
INT J ENV RES PUB HE. 2022; 19(1):
Full papers/articles (Journal)

Diagnostic value of MRI in the presurgical evaluation of patients with epilepsy: influence of field strength and sequence selection: a systematic review and meta-analysis from the E-PILEPSY Consortium
Rados, M; Mouthaan, B; Barsi, P; Carmichael, D; Heckemann, RA; Kelemen, A; Kobulashvili, T; Kuchukhidze, G; Marusic, P; Minkin, K; Tisdall, M; Trinka, E; Veersema, T; Vos, SB; Wagner, J; Braun, K; van Eijsden, P
EPILEPTIC DISORD. 2022; 24(2): 323-342.
Reviews

Assessment of Treatment Response to Lenvatinib in Thyroid Cancer Monitored by F-18 FDG PET/CT Using PERCIST 1.0, Modified PERCIST and EORTC Criteria-Which One Is Most Suitable?
Rendl, G; Schweighofer-Zwink, G; Sorko, S; Gallowitsch, HJ; Hitzl, W; Reisinger, D; Pirich, C
CANCERS. 2022; 14(8):
Full papers/articles (Journal)

Clinico-radiological features, molecular spectrum, and identification of prognostic factors in developmental and epileptic encephalopathy due to inosine triphosphate pyrophosphatase (ITPase) deficiency.
Scala, M; Wortmann, SB; Kaya, N; Stellingwerff, MD; Pistorio, A; Glamuzina, E; van Karnebeek, CD; Skrypnyk, C; Iwanicka-Pronicka, K; Piekutowska-Abramczuk, D; Ciara, E; Tort, F; Sheidley, B; Poduri, A; Jayakar, P; Jayakar, A; Upadia, J; Walano, N; Haack, TB; Prokisch, H; Aldhalaan, H; Karimiani, EG; Yildiz, Y; Ceylan, AC; Santiago-Sim, T; Dameron, A; Yang, H; Toosi, MB; Ashrafzadeh, F; Akhondian, J; Imannezhad, S; Mirzadeh, HS; Maqbool, S; Farid, A; Al-Muhaizea, MA; Alshwameen, MO; Aldowsari, L; Alsagob, M; Alyousef, A; AlMass, R; AlHargan, A; Alwadei, AH; AlRasheed, MM; Colak, D; Alqudairy, H; Khan, S; Lines, MA; García Cazorla, MÁ; Ribes, A; Morava, E; Bibi, F; Haider, S; Ferla, MP; Taylor, JC; Alsaif, HS; Firdous, A; Hashem, M; Shashkin, C; Koneev, K; Kaiyrzhanov, R; Efthymiou, S; Genomics, QS; Schmitt-Mechelke, T; Ziegler, A; Issa, MY; Elbendary, HM; Striano, P; Alkuraya, FS; Zaki, MS; Gleeson, JG; Barakat, TS; Bierau, J; van der Knaap, MS; Maroofian, R; Houlden, H;
Hum Mutat. 2022; 43(3):403-419
Full papers/articles (Journal)

Extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest: A systematic review and meta-analysis of randomized and propensity score-matched studies.
Scquizzato, T; Bonaccorso, A; Consonni, M; Scandroglio, AM; Swol, J; Landoni, G; Zangrillo, A;
Artif Organs. 2022; 46(5): 755-762.
Reviews

Individualised prediction of drug resistance and seizure recurrence after medication withdrawal in people with juvenile myoclonic epilepsy: A systematic review and individual participant data meta-analysis
Stevelink, R; Al-Toma, D; Jansen, FE; Lamberink, HJ; Asadi-Pooya, AA; Farazdaghi, M; Cacao, G; Jayalakshmi, S; Patil, A; Ozkara, C; Aydin, S; Gesche, J; Beier, CP; Stephen, LJ; Brodie, MJ; Unnithan, G; Radhakrishnan, A; Hofler, J; Trinka, E; Krause, R; Irelli, EC; Di Bonaventura, C; Szaflarski, JP; Hernandez-Vanegas, LE; Moya-Alfaro, ML; Zhang, YY; Zhou, D; Pietrafusa, N; Specchio, N; Japaridze, G; Beniczky, S; Janmohamed, M; Kwan, P; Syvertsen, M; Selmer, KK; Vorderwulbecke, BJ; Holtkamp, M; Viswanathan, LG; Sinha, S; Baykan, B; Altindag, E; von Podewils, F; Schulz, J; Seneviratne, U; Viloria-Alebesque, A; Karakis, I; DxxxSouza, WJ; Sander, JW; Koeleman, BPC; Otte, WM; Braun, KPJ
ECLINICALMEDICINE. 2022; 53: 101732
Full papers/articles (Journal)

Extracorporeal Life Support in Accidental Hypothermia with Cardiac Arrest-A Narrative Review.
Swol, J; Darocha, T; Paal, P; Brugger, H; Podsiadło, P; Kosiński, S; Puślecki, M; Ligowski, M; Pasquier, M;
ASAIO J. 2022; 68(2): 153-162.
Full papers/articles (Journal)

Sustained response to brigatinib in a patient with refractory metastatic pheochromocytoma harboring R1192P anaplastic lymphoma kinase mutation: a case report from the Austrian Group Medical Tumor Therapy next-generation sequencing registry and discussion of the literature.
Heregger, R; Huemer, F; Hutarew, G; Hecht, S; Cheveresan, L; Kotzot, D; Schamschula, E; Rinnerthaler, G; Melchardt, T; Weiss, L; Greil, R;
ESMO Open. 2021; 6(4):100233
Reviews

Dynamic extracorporeal life support: A novel management modality in temporary cardio-circulatory assistance.
Lo Coco, V; Swol, J; De Piero, ME; Massimi, G; Chiarini, G; Broman, LM; Lorusso, R;
Artif Organs. 2021; 45(4): 427-434.
Full papers/articles (Journal)

COVID-19 and Extracorporeal Membrane Oxygenation.
Martucci, G; Słomka, A; Lebowitz, SE; Raffa, GM; Malvindi, PG; Coco, VL; Swol, J; Żekanowska, E; Lorusso, R; Wierzba, W; Suwalski, P; Kowalewski, M;
Adv Exp Med Biol. 2021; 1353: 173-195.
Full papers/articles (Journal)

The fate of patients after failed epicardial ablation of atrial fibrillation.
Nasso, G; Lorusso, R; Motekallemi, A; DellAquila, AM; Di Bari, N; Condello, I; Moscarelli, M; Iacopino, S; Serraino, GF; Mastroroberto, P; Santarpino, G; Speziale, G;
J Cardiothorac Surg. 2021; 16(1): 249
Full papers/articles (Journal)

Managing patients on extracorporeal membrane oxygenation support during the COVID-19 pandemic - a proposal for a nursing standard operating procedure.
Puslecki, M; Dabrowski, M; Baumgart, K; Ligowski, M; Dabrowska, A; Ziemak, P; Stefaniak, S; Szarpak, L; Friedrich, T; Szlanga, L; Skorupa, P; Steliga, A; Hebel, K; Andrejanczyk, B; Ladzinska, M; Wieczorek, M; Puslecki, L; Smereka, J; Tukacs, M; Swol, J; Jemielity, M; Perek, B;
BMC Nurs. 2021; 20(1): 214
Full papers/articles (Journal)

Tafasitamab combined with idelalisib or venetoclax in patients with CLL previously treated with a BTK inhibitor.
Staber, PB; Jurczak, W; Greil, R; Vucinic, V; Middeke, JM; Montillo, M; Munir, T; Neumeister, P; Schetelig, J; Stilgenbauer, S; Striebel, F; Dirnberger-Hertweck, M; Weirather, J; Brugger, W; Kelemen, P; Wendtner, CM; Woyach, JA;
Leuk Lymphoma. 2021; 62(14): 3440-3451.
Full papers/articles (Journal)

Subcutaneous administration of levothyroxine: a novel approach to refractory hypothyroidism - A review and a case report.
Topf, A; Pleininger, T; Motloch, LJ; Mirna, M; Kopp, K; Lichtenauer, M; Hoppe, UC; Salmhofer, H;
Arch Endocrinol Metab. 2021; 65(5):664-668
Case Reports

Bullous Pemphigoid Associated with Anti-programmed Cell Death Protein 1 and Anti-programmed Cell Death Ligand 1 Therapy: A Review of the Literature.
Tsiogka, A; Bauer, JW; Patsatsi, A
ACTA DERM-VENEREOL. 2021; 101(1): adv00377
Reviews

Efficacy, Retention and Tolerability of Everolimus in Patients with Tuberous Sclerosis Complex: A Survey-Based Study on Patients" Perspectives.
Willems, LM; Rosenow, F; Schubert-Bast, S; Kurlemann, G; Zollner, JP; Bast, T; Bertsche, A; Bettendorf, U; Ebrahimi-Fakhari, D; Grau, J; Hahn, A; Hartmann, H; Hertzberg, C; Hornemann, F; Immisch, I; Jacobs, J; Klein, KM; Klotz, KA; Kluger, G; Knake, S; Knuf, M; Marquard, K; Mayer, T; Meyer, S; Muhle, H; Muller-Schluter, K; von Podewils, F; Ruf, S; Sauter, M; Schafer, H; Schlump, JU; Syrbe, S; Thiels, C; Trollmann, R; Wiemer-Kruel, A; Wilken, B; Zukunft, B; Strzelczyk, A
CNS DRUGS. 2021; 35(10): 1107-1122.
Full papers/articles (Journal)

Extracorporeal Life Support in Hemorrhagic Conditions: A Systematic Review.
Willers, A; Swol, J; Kowalewski, M; Raffa, GM; Meani, P; Jiritano, F; Matteucci, M; Fina, D; Heuts, S; Bidar, E; Natour, E; Sels, JW; Delnoij, T; Lorusso, R;
ASAIO J. 2021; 67(5):476-484
Reviews

[Surgical decompression of the peroneal nerve at the level of the fibular head].
Heinrich, K; Pumberger, P; Schwaiger, K; Schaffler, G; Hladik, M; Wechselberger, G;
Oper Orthop Traumatol. 2020; 32(5):467-474
Reviews

Combination Strategies for Immune-Checkpoint Blockade and Response Prediction by Artificial Intelligence.
Huemer, F; Leisch, M; Geisberger, R; Melchardt, T; Rinnerthaler, G; Zaborsky, N; Greil, R;
Int J Mol Sci. 2020; 21(8):
Reviews

Antibiofilm activity of antifungal drugs, including the novel drug olorofim, against Lomentospora prolificans.
Kirchhoff, L; Dittmer, S; Weisner, AK; Buer, J; Rath, PM; Steinmann, J;
J Antimicrob Chemother. 2020; 75(8): 2133-2140.
Full papers/articles (Journal)

Antiepileptic therapy approaches in KCNQ2 related epilepsy: A systematic review.
Kuersten, M; Tacke, M; Gerstl, L; Hoelz, H; Stülpnagel, CV; Borggraefe, I;
Eur J Med Genet. 2020; 63(1): 103628
Reviews

Quality of life in patients with relapsed/refractory multiple myeloma during ixazomib-thalidomide-dexamethasone induction and ixazomib maintenance therapy and comparison to the general population.
Ludwig, H; Ponisch, W; Knop, S; Egle, A; Hinke, A; Schreder, M; Lechner, D; Hajek, R; Gunsilius, E; Petzer, A; Weisel, K; Niederwieser, D; Einsele, H; Willenbacher, W; Rumpold, H; Pour, L; Jelinek, T; Krenosz, KJ; Meckl, A; Nolte, S; Melchardt, T; Greil, R; Zojer, N
Leuk Lymphoma. 2020; 61(2):377-386
Full papers/articles (Journal)

Targeted Palliative Radionuclide Therapy for Metastatic Bone Pain.
Manafi-Farid, R; Masoumi, F; Divband, G; Saidi, B; Ataeinia, B; Hertel, F; Schweighofer-Zwink, G; Morgenroth, A; Beheshti, M;
J Clin Med. 2020; 9(8):
Reviews

Presurgical Language fMRI in Children, Adolescents and Young Adults : A Validation Study.
Meinhold, T; Hofer, W; Pieper, T; Kudernatsch, M; Staudt, M;
Clin Neuroradiol. 2020; 30(4):691-704
Full papers/articles (Journal)

Uncovering homonymous visual field defects in candidates for pediatric epilepsy surgery.
Neumayr, L; Pieper, T; Kudernatsch, M; Trauzettel-Klosinski, S; Staudt, M;
EUR J PAEDIATR NEURO. 2020; 25: 165-171.
Full papers/articles (Journal)

Real-World Data for Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer (RELEVANT): A Retrospective Multicentric Analysis of Clinical Practice in Austria.
Rendl, G; Sipos, B; Becherer, A; Sorko, S; Trummer, C; Raderer, M; Hitzl, W; Ardelt, M; Gallowitsch, HJ; Pirich, C;
Int J Endocrinol. 2020; 2020: 8834148
Full papers/articles (Journal)

Artificial lungs--Where are we going with the lung replacement therapy?
Swol, J; Shigemura, N; Ichiba, S; Steinseifer, U; Anraku, M; Lorusso, R;
Artif Organs. 2020; 44(11):1135-1149
Reviews

[Management of refractory and super-refractory status epilepticus].
Erbguth, F;
Med Klin Intensivmed Notfmed. 2019; 114(7):628-634
Reviews

The anesthetic drug treatment of refractory and super-refractory status epilepticus around the world: Results from a global audit.
Ferlisi, M; Hocker, S; Trinka, E; Shorvon, S
EPILEPSY BEHAV. 2019; 101(Pt B): 106449
Full papers/articles (Journal)

Tonic status epilepticus in a centenarian woman.
Fernández-Torre, JL; Riancho, J; Martín-García, M; Martínez-de Las Cuevas, G; Bosque-Varela, P;
Epileptic Disord. 2019; 21(1): 92-96.
Case Reports

Refractory Anaphylaxis: Data From the European Anaphylaxis Registry
Francuzik, W; Dolle-Bierke, S; Knop, M; Hofmeier, KS; Cichocka-Jarosz, E; Garcia, BE; Lang, R; Maris, I; Renaudin, JM; Worm, M
FRONT IMMUNOL. 2019; 10: 2482
Full papers/articles (Journal)

Age-related MR characteristics in mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy (MOGHE).
Hartlieb, T; Winkler, P; Coras, R; Pieper, T; Holthausen, H; Blümcke, I; Staudt, M; Kudernatsch, M;
Epilepsy Behav. 2019; 91:68-74
Full papers/articles (Journal)

MEEGIPS-A Modular EEG Investigation and Processing System for Visual and Automated Detection of High Frequency Oscillations
Holler, P; Trinka, E; Holler, Y
FRONT NEUROINFORM. 2019; 13: 20
Full papers/articles (Journal)

Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM.
Huemer, F; Melchardt, T; Jansko, B; Wahida, A; Jilg, S; Jost, PJ; Klieser, E; Katja, S; Magnes, T; Pleyer, L; Greil-Ressler, S; Rass, C; Greil, R; Egle, A;
Eur J Haematol. 2019; 102(5): 437-441.
Full papers/articles (Journal)

Plitidepsin: a potential new treatment for relapsed/refractory multiple myeloma.
Leisch, M; Egle, A; Greil, R;
Future Oncol. 2019; 15(2):109-120
Full papers/articles (Journal)

Therapeutic Plasma Exchange in Multiple Sclerosis and Autoimmune Encephalitis: a Comparative Study of Indication, Efficacy and Safety.
Moser, T; Harutyunyan, G; Karamyan, A; Otto, F; Bacher, C; Chroust, V; Leitinger, M; Novak, HF; Trinka, E; Sellner, J;
Brain Sci. 2019; 9(10):
Full papers/articles (Journal)

Blood markers of cardiac stress after generalized convulsive seizures.
Nass, RD; Motloch, LJ; Paar, V; Lichtenauer, M; Baumann, J; Zur, B; Hoppe, UC; Holdenrieder, S; Elger, CE; Surges, R;
Epilepsia. 2019; 60(2): 201-210.
Full papers/articles (Journal)

Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma.
Spicka, I; Ocio, EM; Oakervee, HE; Greil, R; Banh, RH; Huang, SY; DxxxRozario, JM; Dimopoulos, MA; Martinez, S; Extremera, S; Kahatt, C; Alfaro, V; Carella, AM; Meuleman, N; Hajek, R; Symeonidis, A; Min, CK; Cannell, P; Ludwig, H; Sonneveld, P; Mateos, MV
ANN HEMATOL. 2019; 98(9): 2139-2150.
Full papers/articles (Journal)

Perampanel for treatment of status epilepticus in Austria, Finland, Germany, and Spain.
Strzelczyk, A; Knake, S; Kälviäinen, R; Santamarina, E; Toledo, M; Willig, S; Rohracher, A; Trinka, E; Rosenow, F;
Acta Neurol Scand. 2019; 139(4): 369-376.
Full papers/articles (Journal)

Neurostimulation in the treatment of refractory and super-refractory status epilepticus.
Trinka, E; Brigo, F
EPILEPSY BEHAV. 2019; 101(Pt B): 106551
Reviews

PRUNE1 Deficiency: Expanding the Clinical and Genetic Spectrum.
Alhaddad, B; Schossig, A; Haack, TB; Kovács-Nagy, R; Braunisch, MC; Makowski, C; Senderek, J; Vill, K; Müller-Felber, W; Strom, TM; Krabichler, B; Freisinger, P; Deshpande, C; Polster, T; Wolf, NI; Desguerre, I; Wörmann, F; Rötig, A; Ahting, U; Kopajtich, R; Prokisch, H; Meitinger, T; Feichtinger, RG; Mayr, JA; Jungbluth, H; Hubmann, M; Zschocke, J; Distelmaier, F; Koch, J;
Neuropediatrics. 2018; 49(5):330-338
Full papers/articles (Journal)

Etiologies and characteristics of refractory status epilepticus cases in different areas of the world: Results from a global audit.
Ferlisi, M; Hocker, S; Trinka, E; Shorvon, S;
Epilepsia. 2018; 59 Suppl 2: 100-107.
Full papers/articles (Journal)

Super-refractory nonconvulsive status epilepticus due to self-poisoning with metaldehyde.
Fernández-Torre, JL; Paramio-Paz, A; Rodríguez-Borregán, JC; Orizaola, P; Bosque-Varela, P; Hernández-Hernández, MA;
J Clin Neurosci. 2018; 47: 134-136.
Case Reports

Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions
Hirsch, LJ; Gaspard, N; van Baalen, A; Nabbout, R; Demeret, S; Loddenkemper, T; Navarro, V; Specchio, N; Lagae, L; Rossetti, AO; Hocker, S; Gofton, TE; Abend, NS; Gilmore, EJ; Hahn, C; Khosravani, H; Rosenow, F; Trinka, E
EPILEPSIA. 2018; 59(4): 739-744.
Reviews

Intravenous ketamine in status epilepticus.
Höfler, J; Trinka, E;
Epilepsia. 2018; 59 Suppl 2: 198-206.
Full papers/articles (Journal)

SENSE registry for status epilepticus.
Kellinghaus, C; Rossetti, AO; Trinka, E; Lang, N; Unterberger, I; Rüegg, S; Tilz, C; Uzelac, Z; Rosenow, F;
Epilepsia. 2018; 59 Suppl 2: 150-154.
Reviews

Influence of titration schedule and maintenance dose on the tolerability of adjunctive eslicarbazepine acetate: An integrated analysis of three randomized placebo-controlled trials.
Krauss, G; Biton, V; Harvey, JH; Elger, C; Trinka, E; Soares da Silva, P; Gama, H; Cheng, H; Grinnell, T; Blum, D;
Epilepsy Res. 2018; 139:1-8
Full papers/articles (Journal)

Benefit of magnetic source localization in challenging refractory epilepsies
Kreidenhuber, R; Demarchi, G; Kalss, G; Leitinger, M; Winkler, PA; Trinka, E; Rampp, S
Z EPILEPTOL. 2018; 31(3): 179-184.
Full papers/articles (Journal)

S100B, Homocysteine, Vitamin B12, Folic Acid, and Procalcitonin Serum Levels in Remitters to Electroconvulsive Therapy: A Pilot Study.
Maier, H; Helm, S; Toto, S; Moschny, N; Sperling, W; Hillemacher, T; Kahl, KG; Jakubovski, E; Bleich, S; Frieling, H; Neyazi, A;
Dis Markers. 2018; 2018: 2358451
Full papers/articles (Journal)

Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit: A single-center audit of 30 patients.
Rohracher, A; Kalss, G; Neuray, C; Höfler, J; Dobesberger, J; Kuchukhidze, G; Kreidenhuber, R; Florea, C; Thomschewski, A; Novak, HF; Pilz, G; Leitinger, M; Trinka, E;
Epilepsia. 2018; 59 Suppl 2: 234-242.
Full papers/articles (Journal)

Adjunctive eslicarbazepine acetate: A pooled analysis of three phase III trials.
Biton, V; Rogin, JB; Krauss, G; Abou-Khalil, B; Rocha, JF; Moreira, J; Gama, H; Trinka, E; Elger, CE; Cheng, HL; Grinnell, T; Blum, D
Epilepsy Behav. 2017; 72:127-134
Full papers/articles (Journal)

Topiramate in the Treatment of Generalized Convulsive Status Epilepticus in Adults: A Systematic Review with Individual Patient Data Analysis.
Brigo, F; Bragazzi, NL; Igwe, SC; Nardone, R; Trinka, E
DRUGS. 2017; 77(1): 67-74.
Reviews

Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.
Brissot, E; Labopin, M; Stelljes, M; Ehninger, G; Schwerdtfeger, R; Finke, J; Kolb, HJ; Ganser, A; Schafer-Eckart, K; Zander, AR; Bunjes, D; Mielke, S; Bethge, WA; Milpied, N; Kalhs, P; Blau, IW; Kroger, N; Vitek, A; Gramatzki, M; Holler, E; Schmid, C; Esteve, J; Mohty, M; Nagler, A
J HEMATOL ONCOL. 2017; 10(1): 130
Full papers/articles (Journal)

Pooled efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: Data from four double-blind placebo-controlled pivotal phase III clinical studies.
Elger, C; Koepp, M; Trinka, E; Villanueva, V; Chaves, J; Ben-Menachen, E; Kowacs, PA; Gil-Nagel, A; Moreira, J; Gama, H; Rocha, JF; Soares-da-Silva, P
CNS NEUROSCI THER. 2017; 23(12): 961-972.
Full papers/articles (Journal)

Mortality, morbidity and refractoriness prediction in status epilepticus: Comparison of STESS and EMSE scores.
Giovannini, G; Monti, G; Tondelli, M; Marudi, A; Valzania, F; Leitinger, M; Trinka, E; Meletti, S;
Seizure. 2017; 46: 31-37.
Full papers/articles (Journal)

Biofilm formation of the black yeast-like fungus Exophiala dermatitidis and its susceptibility to antiinfective agents.
Kirchhoff, L; Olsowski, M; Zilmans, K; Dittmer, S; Haase, G; Sedlacek, L; Steinmann, E; Buer, J; Rath, PM; Steinmann, J;
Sci Rep. 2017; 7: 42886
Full papers/articles (Journal)

Microcystic adnexal carcinoma (MAC)-like squamous cell carcinoma as a differential diagnosis to Bell´s palsy: review of guidelines for refractory facial nerve palsy.
Mueller, SK; Iro, H; Lell, M; Seifert, F; Bohr, C; Scherl, C; Agaimy, A; Traxdorf, M;
J Otolaryngol Head Neck Surg. 2017; 46(1): 1
Case Reports

Refractory plasmablastic lymphoma-a review of treatment options beyond standard therapy.
Pretscher, D; Kalisch, A; Wilhelm, M; Birkmann, J;
Ann Hematol. 2017; 96(6):967-970
Case Reports

The first meeting of the Austrian Expert Panel for Molecular Cancer Profiling
Seeber, A; Gastl, G; Eisterer, W; Gampenrieder, SP; Gerger, A; Kieler, M; Pichler, M; Prager, GW; Untergasser, G; Weltermann, A; Greil, R
MEMO-MAG EUR MED ONC. 2017; 10(4): 255-258.
Full papers/articles (Journal)

25 years of advances in the definition, classification and treatment of status epilepticus.
Trinka, E; Kälviäinen, R;
Seizure. 2017; 44:65-73
Full papers/articles (Journal)

Febrile Infection-Related Epilepsy Syndrome: Clinical Review and Hypotheses of Epileptogenesis.
van Baalen, A; Vezzani, A; Häusler, M; Kluger, G;
Neuropediatrics. 2017; 48(1):5-18
Full papers/articles (Journal)

Current standards of neuropsychological assessment in epilepsy surgery centers across Europe.
Vogt, VL; Äikiä, M; Del Barrio, A; Boon, P; Borbély, C; Bran, E; Braun, K; Carette, E; Clark, M; Cross, JH; Dimova, P; Fabo, D; Foroglou, N; Francione, S; Gersamia, A; Gil-Nagel, A; Guekht, A; Harrison, S; Hecimovic, H; Heminghyt, E; Hirsch, E; Javurkova, A; Kälviäinen, R; Kavan, N; Kelemen, A; Kimiskidis, VK; Kirschner, M; Kleitz, C; Kobulashvili, T; Kosmidis, MH; Kurtish, SY; Lesourd, M; Ljunggren, S; Lossius, MI; Malmgren, K; Mameniskiené, R; Martin-Sanfilippo, P; Marusic, P; Miatton, M; Özkara, Ç; Pelle, F; Rubboli, G; Rudebeck, S; Ryvlin, P; van Schooneveld, M; Schmid, E; Schmidt, PM; Seeck, M; Steinhoff, BJ; Shavel-Jessop, S; Tarta-Arsene, O; Trinka, E; Viggedal, G; Wendling, AS; Witt, JA; Helmstaedter, C;
Epilepsia. 2017; 58(3): 34-355.
Full papers/articles (Journal)

Surgical Myectomy after Failed Ablation for Hypertrophic Obstructive Cardiomyopathy.
Bougioukas, I; Hoppe, U; Danner, B; Schoendube, FA;
Thorac Cardiovasc Surg Rep. 2016; 5(1): 30-32.
Case Reports

(S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study.
Höfler, J; Rohracher, A; Kalss, G; Zimmermann, G; Dobesberger, J; Pilz, G; Leitinger, M; Kuchukhidze, G; Butz, K; Taylor, A; Novak, H; Trinka, E;
CNS Drugs. 2016; 30(9):869-876
Full papers/articles (Journal)

An international, multicenter, prospective, observational study of neutropenia in patients being treated with lenalidomide + dexamethasone for relapsed or relapsed/refractory multiple myeloma (RR-MM).
Leleu, X; Terpos, E; Sanz, RG; Cooney, J; OGorman, P; Minarik, J; Greil, R; Williams, C; Gray, D; Szabo, Z;
Am J Hematol. 2016; 91(8):806-811
Full papers/articles (Journal)

GRIN2D Recurrent De Novo Dominant Mutation Causes a Severe Epileptic Encephalopathy Treatable with NMDA Receptor Channel Blockers.
Li, D; Yuan, HJ; Ortiz-Gonzalez, XR; Marsh, ED; Tian, LF; McCormick, EM; Kosobucki, GJ; Chen, WJ; Schulien, AJ; Chiavacci, R; Tankovic, A; Naase, C; Brueckner, F; von Stulpnagel-Steinbeis, C; Hu, C; Kusumoto, H; Hedrich, UBS; Elsen, G; Hortnagel, K; Aizenman, E; Lemke, JR; Hakonarson, H; Traynelis, SF; Falk, MJ
AM J HUM GENET. 2016; 99(4): 802-816.
Full papers/articles (Journal)

Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance.
Mebazaa, A; Tolppanen, H; Mueller, C; Lassus, J; DiSomma, S; Baksyte, G; Cecconi, M; Choi, DJ; Cohen Solal, A; Christ, M; Masip, J; Arrigo, M; Nouira, S; Ojji, D; Peacock, F; Richards, M; Sato, N; Sliwa, K; Spinar, J; Thiele, H; Yilmaz, MB; Januzzi, J;
Intensive Care Med. 2016; 42(2): 147-163.
Full papers/articles (Journal)

Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones.
Melchardt, T; Hufnagl, C; Weinstock, DM; Kopp, N; Neureiter, D; Tränkenschuh, W; Hackl, H; Weiss, L; Rinnerthaler, G; Hartmann, TN; Greil, R; Weigert, O; Egle, A;
Oncotarget. 2016; 7(32):51494-51502
Full papers/articles (Journal)

[Standardisation of the Initial Treatment of Severely Burned Patients: The Necessary Transfer of Concepts from Trauma Care].
Münzberg, M; Harbers, T; Kneser, U; Grützner, PA; Reichert, B; Kremer, T; Wölfl, CG; Horter, J; Hirche, C;
Zentralbl Chir. 2016; 141(6):654-659
Full papers/articles (Journal)

[Transitional fractures : Epiphyseal injuries in adolescence].
Schneidmueller, D; von Rüden, C; Friederichs, J; Bühren, V;
Unfallchirurg. 2016; 119(6): 517-526.
Full papers/articles (Journal)

Recent advances in status epilepticus.
Trinka, E; Brigo, F; Shorvon, S;
Curr Opin Neurol. 2016; 29(2): 189-198.
Full papers/articles (Journal)

Pharmacologic treatment of status epilepticus.
Trinka, E; Höfler, J; Leitinger, M; Rohracher, A; Kalss, G; Brigo, F;
Expert Opin Pharmacother. 2016; 17(4):51-34
Full papers/articles (Journal)

Perampanel for focal epilepsy: insights from early clinical experience.
Trinka, E; Steinhoff, BJ; Nikanorova, M; Brodie, MJ;
Acta Neurol Scand. 2016; 133(3): 160-172.
Reviews

Long-term intravenous inotropes in low-output terminal heart failure?
von Scheidt, W; Pauschinger, M; Ertl, G
Clin Res Cardiol. 2016; 105(6):471-481
Full papers/articles (Journal)

Low Beclin-1 expression predicts improved overall survival in patients treated with immunomodulatory drugs for multiple myeloma and identifies autophagy inhibition as a promising potentially druggable new therapeutic target: an analysis from The Austrian Myeloma Registry (AMR).
Willenbacher, W; Thangavadivel, S; Greil, R; Willenbacher, E; Weger, R; Manzl, C; Jöhrer, K; Brunner, A;
Leuk Lymphoma. 2016; 57(10):2330-2341
Full papers/articles (Journal)

Effectiveness and tolerability of perampanel in children and adolescents with refractory epilepsies: first experiences.
Biro, A; Stephani, U; Tarallo, T; Bast, T; Schlachter, K; Fleger, M; Kurlemann, G; Fiedler, B; Leiz, S; Nikanorova, M; Wolff, M; Muller, A; Selch, C; Staudt, M; Kluger, G
NEUROPEDIATRICS. 2015; 46(2): 110-115.
Full papers/articles (Journal)

Preliminary results of the global audit of treatment of refractory status epilepticus.
Ferlisi, M; Hocker, S; Grade, M; Trinka, E; Shorvon, S
Epilepsy Behav. 2015; 49:318-324
Full papers/articles (Journal)

Supraciliary Micro-stent Implantation for Open-Angle Glaucoma Failing Topical Therapy: 1-Year Results of a Multicenter Study.
García-Feijoo, J; Rau, M; Grisanti, S; Grisanti, S; Höh, H; Erb, C; Guguchkova, P; Ahmed, I; Grabner, G; Reitsamer, H; Shaarawy, T; Ianchulev, T;
Am J Ophthalmol. 2015; 159(6):1075-1081.e1
Full papers/articles (Journal)

Mortality and SUDEP in epilepsy patients treated with vagus nerve stimulation
Granbichler, CA; Nashef, L; Selway, R; Polkey, CE
EPILEPSIA. 2015; 56(2): 291-296.
Full papers/articles (Journal)

Hemispherectomy for treatment of refractory epilepsy in the pediatric age group: a systematic review.
Griessenauer, CJ; Salam, S; Hendrix, P; Patel, DM; Tubbs, RS; Blount, JP; Winkler, PA;
J NEUROSURG-PEDIATR. 2015; 15(1): 3-44.
Full papers/articles (Journal)

High-frequency oscillations in epilepsy and surgical outcome. A meta-analysis.
Holler, Y; Kutil, R; Klaffenbock, L; Thomschewski, A; Holler, PM; Bathke, AC; Jacobs, J; Taylor, AC; Nardone, R; Trinka, E
FRONT HUM NEUROSCI. 2015; 9: 574
Full papers/articles (Journal)

Making SENSE--Sustained Effort Network for treatment of Status Epilepticus as a multicenter prospective registry.
Kellinghaus, C; Lang, N; Rossetti, AO; Ruegg, S; Tilz, C; Trinka, E; Unterberger, I; Uzelac, Z; Rosenow, F
BMC NEUROL. 2015; 15: 230
Full papers/articles (Journal)

The phenotypic spectrum of SCN8A encephalopathy.
Larsen, J; Carvill, GL; Gardella, E; Kluger, G; Schmiedel, G; Barisic, N; Depienne, C; Brilstra, E; Mang, Y; Nielsen, JE; Kirkpatrick, M; Goudie, D; Goldman, R; Jähn, JA; Jepsen, B; Gill, D; Döcker, M; Biskup, S; McMahon, JM; Koeleman, B; Harris, M; Braun, K; de Kovel, CG; Marini, C; Specchio, N; Djémié, T; Weckhuysen, S; Tommerup, N; Troncoso, M; Troncoso, L; Bevot, A; Wolff, M; Hjalgrim, H; Guerrini, R; Scheffer, IE; Mefford, HC; Møller, RS;
Neurology. 2015; 84(5): 480-489.
Full papers/articles (Journal)

[Therapie des Patienten mit Radioiod-refraktärem, differenziertem Schilddrüsenkarzinom. Ein Konsensusstatement].
Lindner, C; Dierneder, J; Pall, G; Pirich, C; Hoffmann, M; Raderer, M; Becherer, A; Niederle, B; Lipp, R; Lind, P; Gallowitsch, H; Romeder, F; Virgolini, I;
Nuklearmedizin. 2015; 54(3): 125-130.
Full papers/articles (Journal)

Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit.
Rohracher, A; Hofler, J; Kalss, G; Leitinger, M; Kuchukhidze, G; Deak, I; Dobesberger, J; Novak, H; Pilz, G; Zerbs, A; Trinka, E
EPILEPSY BEHAV. 2015; 49: 354-358.
Full papers/articles (Journal)

Polymorphisms in Genes Involved in EGFR Turnover Are Predictive for Cetuximab Efficacy in Colorectal Cancer.
Stintzing, S; Zhang, W; Heinemann, V; Neureiter, D; Kemmerling, R; Kirchner, T; Jung, A; Folwaczny, M; Yang, D; Ning, Y; Sebio, A; Stremitzer, S; Sunakawa, Y; Matsusaka, S; Yamauchi, S; Loupakis, F; Cremolini, C; Falcone, A; Lenz, HJ;
Mol Cancer Ther. 2015; 14(10): 2374-2381.
Full papers/articles (Journal)

Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML-long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL)†.
Thiel, A; Schetelig, J; Pönisch, W; Schäfer-Eckart, K; Aulitzky, W; Peter, N; Schulze, A; Maschmeyer, G; Neugebauer, S; Herbst, R; Hänel, A; Morgner, A; Kroschinsky, F; Bornhäuser, M; Lange, T; Wilhelm, M; Niederwieser, D; Ehninger, G; Fiedler, F; Hänel, M;
Ann Oncol. 2015; 26(7): 143-140.
Full papers/articles (Journal)

Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.
Byrd, JC; Brown, JR; O"Brien, S; Barrientos, JC; Kay, NE; Reddy, NM; Coutre, S; Tam, CS; Mulligan, SP; Jaeger, U; Devereux, S; Barr, PM; Furman, RR; Kipps, TJ; Cymbalista, F; Pocock, C; Thornton, P; Caligaris-Cappio, F; Robak, T; Delgado, J; Schuster, SJ; Montillo, M; Schuh, A; de Vos, S; Gill, D; Bloor, A; Dearden, C; Moreno, C; Jones, JJ; Chu, AD; Fardis, M; McGreivy, J; Clow, F; James, DF; Hillmen, P;
N Engl J Med. 2014; 371(3): 213-223.
Full papers/articles (Journal)

Transition issues for children with diffuse cortical malformations, multifocal postnatal lesions, (infectious and traumatic) and Lennox-Gastaut and similar syndromes.
Camfield, PR; Bahi-Buisson, N; Trinka, E
EPILEPSIA. 2014; 55 Suppl 3: 24-28.
Full papers/articles (Journal)

Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses.
Coiffier, B; Pro, B; Prince, HM; Foss, F; Sokol, L; Greenwood, M; Caballero, D; Morschhauser, F; Wilhelm, M; Pinter-Brown, L; Iyer, SP; Shustov, A; Nielsen, T; Nichols, J; Wolfson, J; Balser, B; Horwitz, S
J Hematol Oncol. 2014; 7:11
Full papers/articles (Journal)

Fulminant systemic capillary leak syndrome due to C1 inhibitor deficiency complicating acute dermatomyositis: a case report.
Gradwohl-Matis, I; Illig, R; Salmhofer, H; Neureiter, D; Brunauer, A; Dünser, MW;
J Med Case Rep. 2014; 8:28
Full papers/articles (Journal)

Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial.
Hopfinger, G; Nösslinger, T; Lang, A; Linkesch, W; Melchardt, T; Weiss, L; Egle, A; Greil, R;
Ann Hematol. 2014; 93(3):459-462
Full papers/articles (Journal)

The consequences of refractory epilepsy and its treatment
Laxer, KD; Trinka, E; Hirsch, LJ; Cendes, F; Langfitt, J; Delanty, N; Resnick, T; Benbadis, SR
EPILEPSY BEHAV. 2014; 37: 59-70.
Reviews

Epilepsy in Aicardi-Goutières syndrome.
Ramantani, G; Maillard, LG; Bast, T; Husain, RA; Niggemann, P; Kohlhase, J; Hertzberg, C; Ungerath, K; Innes, MA; Walkenhorst, H; Bevot, A; von Stülpnagel, C; Thomas, K; Niemann, F; Ergun, MA; Tacke, U; Häusler, M; Ikonomidou, C; Korinthenberg, R; Lee-Kirsch, MA;
Eur J Paediatr Neurol. 2014; 18(1): 30-37.
Full papers/articles (Journal)

[Quality guidelines for presurgical epilepsy diagnosis and operative epilepsy therapy : 1st revised version].
Rosenow, F; Bast, T; Czech, T; Hans, V; Helmstaedter, C; Huppertz, HJ; Seeck, M; Trinka, E; Wagner, K;
Nervenarzt. 2014; 85(6): 753-756.
Full papers/articles (Journal)

[Dialysis and ultrafiltration therapy in patients with cardio-renal syndrome: recommendations of the working group "heart-kidney" of the German Cardiac Society and the German Society of Nephrology].
Schwenger, V; Remppis, BA; Westenfeld, R; Weinreich, T; Brunkhorst, R; Schieren, G; Krumme, B; Haller, H; Schmieder, R; Schlieper, G; Frye, B; Hoppe, UC; Hoyer, J; Keller, T; Blumenstein, M; Schunkert, H; Mahfoud, F; Rump, LC
DEUT MED WOCHENSCHR. 2014; 139(7): e1-e8.
Reviews

Intravenous sildenafil i.v. as rescue treatment for refractory pulmonary hypertension in extremely preterm infants.
Steiner, M; Salzer, U; Baumgartner, S; Waldhoer, T; Klebermass-Schrehof, K; Wald, M; Langgartner, M; Berger, A;
Klin Padiatr. 2014; 226(4):211-215
Full papers/articles (Journal)

Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells.
Wilhelm, M; Smetak, M; Schaefer-Eckart, K; Kimmel, B; Birkmann, J; Einsele, H; Kunzmann, V
J Transl Med. 2014; 12:45
Full papers/articles (Journal)

Infections in status epilepticus: A retrospective 5-year cohort study.
Zelano, J; Möller, F; Dobesberger, J; Trinka, E; Kumlien, E;
Seizure. 2014; 23(8): 603-606.
Full papers/articles (Journal)

The established status epilepticus trial 2013.
Bleck, T; Cock, H; Chamberlain, J; Cloyd, J; Connor, J; Elm, J; Fountain, N; Jones, E; Lowenstein, D; Shinnar, S; Silbergleit, R; Treiman, D; Trinka, E; Kapur, J;
Epilepsia. 2013; 54 Suppl 6: 89-92.
Full papers/articles (Journal)

Rufinamide for refractory focal seizures: an open-label, multicenter European study.
Coppola, G; Zamponi, N; Kluger, G; Mueller, A; Anna Rita, M; Parisi, P; Isone, C; Santoro, E; Curatolo, P; Verrotti, A;
Seizure. 2013; 22(1): 33-36.
Full papers/articles (Journal)

Lacosamide as a new treatment option in status epilepticus.
Höfler, J; Trinka, E;
Epilepsia. 2013; 54(3):393-404
Reviews

Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia.
Hopfinger, G; Busch, R; Pflug, N; Weit, N; Westermann, A; Fink, AM; Cramer, P; Reinart, N; Winkler, D; Fingerle-Rowson, G; Stilgenbauer, S; Döhner, H; Kandler, G; Eichhorst, B; Hallek, M; Herling, M;
Cancer. 2013; 119(12):2258-2267
Full papers/articles (Journal)

Interleukin-22 is frequently expressed in small- and large-cell lung cancer and promotes growth in chemotherapy-resistant cancer cells.
Kobold, S; Völk, S; Clauditz, T; Küpper, NJ; Minner, S; Tufman, A; Düwell, P; Lindner, M; Koch, I; Heidegger, S; Rothenfuer, S; Schnurr, M; Huber, RM; Wilczak, W; Endres, S;
J Thorac Oncol. 2013; 8(8):103-142
Full papers/articles (Journal)

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings.
Kubicka, S; Greil, R; André, T; Bennouna, J; Sastre, J; Van Cutsem, E; von Moos, R; Osterlund, P; Reyes-Rivera, I; Müller, T; Makrutzki, M; Arnold, D;
Ann Oncol. 2013; 24(9):2342-2349
Full papers/articles (Journal)

[Status epilepticus].
Feddersen, B; Trinka, E;
Nervenarzt. 2012; 83(2): 187-194.
Full papers/articles (Journal)

An international expanded-access programme of everolimus: addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy.
Grünwald, V; Karakiewicz, PI; Bavbek, SE; Miller, K; Machiels, JP; Lee, SH; Larkin, J; Bono, P; Rha, SY; Castellano, D; Blank, CU; Knox, JJ; Hawkins, R; Anak, O; Rosamilia, M; Booth, J; Pirotta, N; Bodrogi, I;
Eur J Cancer. 2012; 48(3): 324-332.
Full papers/articles (Journal)

Candidate gene sequencing of SLC11A2 and TMPRSS6 in a family with severe anaemia: common SNPs, rare haplotypes, no causative mutation.
Kloss-Brandstätter, A; Erhart, G; Lamina, C; Meister, B; Haun, M; Coassin, S; Seifert, M; Klein-Franke, A; Paulweber, B; Kedenko, L; Kollerits, B; Swinkels, DW; Vermeulen, SH; Galesloot, TE; Kronenberg, F; Weiss, G;
PLoS One. 2012; 7(4): e35015
Full papers/articles (Journal)

Effectiveness of laparoscopic total and partial fundoplication on extraesophageal manifestations of gastroesophageal reflux disease: a randomized study.
Koch, OO; Antoniou, SA; Kaindlstorfer, A; Asche, KU; Granderath, FA; Pointner, R;
Surg Laparosc Endosc Percutan Tech. 2012; 22(5):387-391
Full papers/articles (Journal)

PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas
Laimer, D; Dolznig, H; Kollmann, K; Vesely, PW; Schlederer, M; Merkel, O; Schiefer, AI; Hassler, MR; Heider, S; Amenitsch, L; Thallinger, C; Staber, PB; Simonitsch-Klupp, I; Artaker, M; Lagger, S; Turner, SD; Pileri, S; Piccaluga, PP; Valent, P; Messana, K; Landra, I; Weichhart, T; Knapp, S; Shehata, M; Todaro, M; Sexl, V; Hofler, G; Piva, R; Medico, E; Ruggeri, BA; Cheng, MG; Eferl, R; Egger, G; Penninger, JM; Jaeger, U; Moriggl, R; Inghirami, G; Kenner, L
NAT MED. 2012; 18(11): 1699-+.
Letters

Immunoadsorption in dermatology.
Meyersburg, D; Schmidt, E; Kasperkiewicz, M; Zillikens, D;
Ther Apher Dial. 2012; 16(4):311-320
Reviews

Neuropathologic measurements in focal cortical dysplasias: validation of the ILAE 2011 classification system and diagnostic implications for MRI.
Mühlebner, A; Coras, R; Kobow, K; Feucht, M; Czech, T; Stefan, H; Weigel, D; Buchfelder, M; Holthausen, H; Pieper, T; Kudernatsch, M; Blümcke, I;
Acta Neuropathol. 2012; 123(2):259-272
Full papers/articles (Journal)

Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases.
Rick, FG; Schally, AV; Szalontay, L; Block, NL; Szepeshazi, K; Nadji, M; Zarandi, M; Hohla, F; Buchholz, S; Seitz, S;
Proc Natl Acad Sci U S A. 2012; 109(5):1655-1660
Full papers/articles (Journal)

Hemodiafiltration in infants with complications during peritoneal dialysis.
Rodl, S; Marschitz, I; Mache, CJ; Nagel, B; Koestenberger, M; Zobel, G
Artif Organs. 2012; 36(7):590-593
Full papers/articles (Journal)

Seizures and epilepsy in herpes simplex virus encephalitis: current concepts and future directions of pathogenesis and management.
Sellner, J; Trinka, E;
J Neurol. 2012; 259(10): 2019-2030.
Reviews

[Renal sympathetic denervation. A novel interventional treatment option for therapy-resistant arterial hypertension].
Brandt, MC; Mahfoud, F; Böhm, M; Hoppe, UC;
Herz. 2011; 36(1): 8-11.
Reviews

Video-EEG monitoring: safety and adverse events in 507 consecutive patients.
Dobesberger, J; Walser, G; Unterberger, I; Seppi, K; Kuchukhidze, G; Larch, J; Bauer, G; Bodner, T; Falkenstetter, T; Ortler, M; Luef, G; Trinka, E;
Epilepsia. 2011; 52(3):443-452
Full papers/articles (Journal)

Intravenous lacosamide in status epilepticus and seizure clusters.
Höfler, J; Unterberger, I; Dobesberger, J; Kuchukhidze, G; Walser, G; Trinka, E;
Epilepsia. 2011; 52(10): e148-e152.
Full papers/articles (Journal)

Febrile infection-related epilepsy syndrome (FIRES): Does duration of anesthesia affect outcome?
Kramer, U; Chi, CS; Lin, KL; Specchio, N; Sahin, M; Olson, H; Kluger, G; van Baalen, A
EPILEPSIA. 2011; 52: 28-30.
Full papers/articles (Journal)

Febrile infection-related epilepsy syndrome (FIRES): Pathogenesis, treatment, and outcome A multicenter study on 77 children
Kramer, U; Chi, CS; Lin, KL; Specchio, N; Sahin, M; Olson, H; Nabbout, R; Kluger, G; Lin, JJ; van Baalen, A
EPILEPSIA. 2011; 52(11): 1956-1965.
Full papers/articles (Journal)

Low long-term efficacy and tolerability of add-on rufinamide in patients with Dravet syndrome
Mueller, A; Boor, R; Coppola, G; Striano, P; Dahlin, M; von Stuelpnagel, C; Lotte, J; Staudt, M; Kluger, G
EPILEPSY BEHAV. 2011; 21(3): 282-284.
Full papers/articles (Journal)

Frame-based vs frameless placement of intrahippocampal depth electrodes in patients with refractory epilepsy: a comparative in vivo (application) study.
Ortler, M; Sohm, F; Eisner, W; Bauer, R; Dobesberger, J; Trinka, E; Widmann, G; Bale, R;
Neurosurgery. 2011; 68(4): 881-887.
Full papers/articles (Journal)

Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID).
Tony, HP; Burmester, G; Schulze-Koops, H; Grunke, M; Henes, J; Kötter, I; Haas, J; Unger, L; Lovric, S; Haubitz, M; Fischer-Betz, R; Chehab, G; Rubbert-Roth, A; Specker, C; Weinerth, J; Holle, J; Müller-Ladner, U; König, R; Fiehn, C; Burgwinkel, P; Budde, K; Sörensen, H; Meurer, M; Aringer, M; Kieseier, B; Erfurt-Berge, C; Sticherling, M; Veelken, R; Ziemann, U; Strutz, F; von Wussow, P; Meier, FM; Hunzelmann, N; Schmidt, E; Bergner, R; Schwarting, A; Eming, R; Hertl, M; Stadler, R; Schwarz-Eywill, M; Wassenberg, S; Fleck, M; Metzler, C; Zettl, U; Westphal, J; Heitmann, S; Herzog, AL; Wiendl, H; Jakob, W; Schmidt, E; Freivogel, K; Dörner, T;
Arthritis Res Ther. 2011; 13(3):R75
Full papers/articles (Journal)

Flexible dosing of adjunctive zonisamide in the treatment of adult partial-onset seizures: a non-comparative, open-label study (ZEUS).
Dupont, S; Striano, S; Trinka, E; Springub, J; Giallonardo, AT; Smith, P; Ellis, S; Yeates, A; Baker, G;
Acta Neurol Scand. 2010; 121(3):141-148
Full papers/articles (Journal)

Dihydropyridine calcium antagonists are associated with increased albuminuria in treatment-resistant hypertensives.
Hummel, D; Raff, U; Schwarz, TK; Schneider, MP; Schmieder, RE; Schmidt, BM;
J Nephrol. 2010; 23(5):563-568
Full papers/articles (Journal)

First European long-term experience with the orphan drug rufinamide in childhood-onset refractory epilepsy
Kluger, G; Haberlandt, E; Kurlemann, G; Ernst, JP; Runge, U; Schneider, F; Makowski, C; Boor, R; Bast, T
EPILEPSY BEHAV. 2010; 17(4): 546-548.
Full papers/articles (Journal)

Complete removal of vagus nerve stimulator generator and electrodes.
Ortler, M; Unterhofer, C; Dobesberger, J; Haberlandt, E; Trinka, E;
J Neurosurg Pediatr. 2010; 5(2): 191-194.
Full papers/articles (Journal)

Proliferative stimulation of the vascular Endothelin-1 axis in vitro and ex vivo by infection with Chlamydia pneumoniae.
Kern, JM; Maass, V; Rupp, J; Maass, M;
THROMB HAEMOSTASIS. 2009; 102(4): 74-53.
Full papers/articles (Journal)

Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: First European experience
Kluger, G; Kurlemann, G; Haberlandt, E; Ernst, JP; Runge, U; Schneider, F; Makowski, C; Boor, R; Bast, T
EPILEPSY BEHAV. 2009; 14(3): 491-495.
Full papers/articles (Journal)

Treatment of bipolar depression: an update.
Fountoulakis, KN; Grunze, H; Panagiotidis, P; Kaprinis, G;
J Affect Disord. 2008; 109(1-2):21-34
Reviews

Long-term use of zonisamide in refractory childhood-onset epilepsy.
Kluger, G; Zsoter, A; Holthausen, H;
Eur J Paediatr Neurol. 2008; 12(1): 19-23.
Full papers/articles (Journal)

Reversal of pathological pain through specific spinal GABAA receptor subtypes.
Knabl, J; Witschi, R; Hösl, K; Reinold, H; Zeilhofer, UB; Ahmadi, S; Brockhaus, J; Sergejeva, M; Hess, A; Brune, K; Fritschy, JM; Rudolph, U; Möhler, H; Zeilhofer, HU;
Nature. 2008; 451(7176): 330-334.
Full papers/articles (Journal)

N-terminal pro-brain natriuretic peptide (NT-proBNP) release in children with vagus nerve stimulation. A prospective case series.
Rauchenzauner, M; Haberlandt, E; Ortler, M; Tatarczyk, T; Laimer, M; Trinka, E; Luef, G;
J Neurol. 2008; 255(7): 980-985.
Full papers/articles (Journal)

Combined pegylated liposomal doxorubicin and bortezomib is highly effective in patients with recurrent or refractory multiple myeloma who received prior thalidomide/lenalidomide therapy.
Sonneveld, P; Hajek, R; Nagler, A; Spencer, A; Bladé, J; Robak, T; Zhuang, SH; Harousseau, JL; Orlowski, RZ;
Cancer. 2008; 112(7): 1529-1537.
Full papers/articles (Journal)

Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone).
Zwick, C; Birkmann, J; Peter, N; Bodenstein, H; Fuchs, R; Hänel, M; Reiser, M; Hensel, M; Clemens, M; Zeynalova, S; Ziepert, M; Pfreundschuh, M;
Ann Hematol. 2008; 87(9):717-726
Full papers/articles (Journal)

Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial.
Boeck, S; Weigang-Köhler, K; Fuchs, M; Kettner, E; Quietzsch, D; Trojan, J; Stötzer, O; Zeuzem, S; Lordick, F; Köhne, CH; Kröning, H; Steinmetz, T; Depenbrock, H; Heinemann, V;
Ann Oncol. 2007; 18(4): 74-51.
Full papers/articles (Journal)

An open trial of levetiracetam for segmental and generalized dystonia.
Hering, S; Wenning, GK; Seppi, K; Poewe, W; Mueller, J;
Mov Disord. 2007; 22(11):1649-1651
Full papers/articles (Journal)

Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy.
von Stuelpnagel, C; Holthausen, H; Kluger, G;
Eur J Paediatr Neurol. 2007; 11(6): 341-345.
Full papers/articles (Journal)

Routine clinical use of alemtuzumab in patients with heavily pretreated B-cell chronic lymphocytic leukemia: a nation-wide retrospective study in Austria.
Fiegl, M; Falkner, A; Hopfinger, G; Brugger, S; Zabernigg, A; Bauer, F; Haslbauer, F; Demirtas, D; Grossschmidt, P; Tatzreiter, G; Gastl, G; Greil, R;
CANCER. 2006; 107(10): 2408-2416.
Full papers/articles (Journal)

Prospective trial on topotecan salvage therapy in primary CNS lymphoma.
Fischer, L; Thiel, E; Klasen, HA; Birkmann, J; Jahnke, K; Martus, P; Korfel, A;
Ann Oncol. 2006; 17(7):1141-1145
Full papers/articles (Journal)

Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I/II study of the German CLL Study Group
Bergmann, MA; Goebeler, ME; Herold, M; Emmerich, B; Wilhelm, M; Ruelfs, C; Boening, L; Hallek, MJ
HAEMATOL-HEMATOL J. 2005; 90(10): 1357-1364.
Full papers/articles (Journal)

Levetiracetam in children with refractory epilepsy: A multicenter open label study in Germany
Opp, J; Tuxhorn, I; May, T; Kluger, G; Wiemer-Kruel, A; Kurlemann, G; Gross-Selbeck, G; Rating, D; Brandl, U; Bettendorf, U; Hartel, C; Korn-Merker, E
SEIZURE-EUR J EPILEP. 2005; 14(7): 476-484.
Full papers/articles (Journal)

Levetiracetam in patients with refractory epilepsy: results of the SKATE trial in Austria, Germany and Switzerland.
Steinhoff, BJ; Trinka, E; Wieser, HG;
Seizure. 2005; 14(7):490-496
Full papers/articles (Journal)

EKG abnormalities in children and adolescents with symptomatic temporal lobe epilepsy.
Mayer, H; Benninger, F; Urak, L; Plattner, B; Geldner, J; Feucht, M
Neurology. 2004; 63(2):324-328
Full papers/articles (Journal)

Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma.
Hänel, M; Kröger, N; Sonnenberg, S; Bornhäuser, M; Krüger, W; Kroschinsky, F; Hänel, A; Metzner, B; Birkmann, J; Schmid, B; Hoffknecht, MM; Fiedler, F; Ehninger, G; Zander, AR;
Ann Hematol. 2002; 81(2): 96-102.
Full papers/articles (Journal)

Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma.
Hänel, M; Kröger, N; Kroschinsky, F; Birkmann, J; Hänel, A; Herbst, R; Naumann, R; Friedrichsen, K; Ehninger, G; Zander, AR; Fiedler, F;
J Cancer Res Clin Oncol. 2001; 127(6):387-395
Full papers/articles (Journal)

Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells.
Fechner, H; Wang, X; Wang, H; Jansen, A; Pauschinger, M; Scherübl, H; Bergelson, JM; Schultheiss, HP; Poller, W;
Gene Ther. 2000; 7(22): 1954-1968.
Full papers/articles (Journal)

DIZE (dexamethasone, idarubicin, and continuous infusion of ifosfamide and etoposide): an effective and well-tolerated new regimen for patients with relapsed lymphoma.
Reiser, M; Schnell, R; Straub, G; Borchmann, P; Wilhelm, M; Ubelacker, R; Wörmann, B; Münch, R; Diehl, V; Engert, A;
Leuk Lymphoma. 1998; 31(3-4): 359-366.
Full papers/articles (Journal)

A phase-II study with idarubicin, ifosfamide and VP-16 (IIVP-16) in patients with refractory or relapsed aggressive and high grade non-Hodgkin"s lymphoma.
Engert, A; Schnell, R; Küpper, F; Reiser, M; Engelhard, M; Wilhelm, M; Lathan, B; Baltes-Engler, S; Winterhalter, B; Scheulen, ME; Dederichs, B; Tesch, H; Wörmann, B; Diehl, V;
Leuk Lymphoma. 1997; 24(5-6): 513-522.
Full papers/articles (Journal)

[Transjugular intrahepatic portasystemic shunt. A new therapeutic method in portal hypertension].
Tesdal, IK; Jaschke, W; Adamus, R; Georgi, M; Filser, T; Holm, E;
Tidsskr Nor Laegeforen. 1996; 116(8): 968-972.
Full papers/articles (Journal)

Ifosfamide, mitoxantrone and etoposide (VIM) as salvage therapy of low toxicity in non-Hodgkin"s lymphoma.
Hopfinger, G; Heinz, R; Koller, E; Schneider, B; Pittermann, E;
Eur J Haematol. 1995; 55(4): 223-227.
Full papers/articles (Journal)